{"title":"Vindesine therapy in melphalan-resistant multiple myeloma","authors":"B. Houwen, Th. Ockhuizen, J. Marrink, H.O. Nieweg","doi":"10.1016/0014-2964(81)90040-2","DOIUrl":null,"url":null,"abstract":"<div><p>Vindesine, a new vinca alkaloid, was administered in thirteen patients with advanced multiple myeloma (stages <em>IIIA</em> and <em>IIIB</em>), resistant to alkylating agents. Eleven patients received two complete courses and could be evaluated. Six patients (<em>55%</em>) showed objective improvement. This was indicated by a decrease of greater than <em>50%</em> of pretreatment myeloma protein serum levels, normalization of elevated serum calcium levels, and improvement of haemoglobin concentration and renal function. Neutropenia of short duration, mild paraesthesias and alopecia were noted as side effects.</p></div>","PeriodicalId":100497,"journal":{"name":"European Journal of Cancer (1965)","volume":"17 2","pages":"Pages 227-232"},"PeriodicalIF":0.0000,"publicationDate":"1981-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/0014-2964(81)90040-2","citationCount":"19","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Cancer (1965)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/0014296481900402","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 19
Abstract
Vindesine, a new vinca alkaloid, was administered in thirteen patients with advanced multiple myeloma (stages IIIA and IIIB), resistant to alkylating agents. Eleven patients received two complete courses and could be evaluated. Six patients (55%) showed objective improvement. This was indicated by a decrease of greater than 50% of pretreatment myeloma protein serum levels, normalization of elevated serum calcium levels, and improvement of haemoglobin concentration and renal function. Neutropenia of short duration, mild paraesthesias and alopecia were noted as side effects.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
